Targeting glucosylceramide synthase downregulates expression of the multidrug resistance gene MDR1 and sensitizes breast carcinoma cells to anticancer drugs

Yanlin Sun, Tingguo Zhang, Peng Gao, Bin Meng, Yongsheng Gao, Xiao Wang, Jianping Zhang, Hao Wang, Xiaojuan Wu, Wenxin Zheng, Gengyin Zhou

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Drug resistance in breast cancer remains a major cause for the failure of chemotherapy. Glucosylceramide synthase (GCS) plays an important role in multidrug resistance (MDR) in breast cancer. P-glycoprotein (P-gp) also confers a cross-resistance of many unrelated drugs. In this study, we studied the MDR effect and potential mechanisms of breast cancer after constructing permanent breast cancer cell lines with GCS knockout by using recombinant vectors targeting GCS (pSUPER-GCSshRNAs). The GCSshRNA stably transfected cells were successfully established and significant lower levels of GCS mRNA and protein expression were confirmed. In in vitro experiments, the GCSshRNA stably transfected cells showed a significantly reduced level of MDR1 and P-gp expression and decreased drug efflux ability. Reduced level of GCS expression conveyed a significant reversal of drug resistance by MTT assay and increased caspase-3 activity. In in vivo experiments by using nude mice with xenograft tumors, a significant inhibition of tumor growth was observed after comparing with the control group. Furthermore, enhanced response of chemotherapy was acquired by reduced expression of GCS as well as MDR1 in vivo. In conclusion, GCSshRNA could efficiently suppress GCS and MDR1 expression in vitro and in vivo and these findings may be used as one of the methods to reverse MDR in breast cancer.

Original languageEnglish (US)
Pages (from-to)591-599
Number of pages9
JournalBreast Cancer Research and Treatment
Volume121
Issue number3
DOIs
StatePublished - Jun 1 2010

Fingerprint

ceramide glucosyltransferase
MDR Genes
Down-Regulation
Breast Neoplasms
Pharmaceutical Preparations
Multiple Drug Resistance
P-Glycoprotein
Drug Resistance
Drug Therapy
Heterografts
Nude Mice
Caspase 3
Neoplasms

Keywords

  • Glucosylceramide synthase
  • MDR1
  • Multidrug resistance
  • Nude mice
  • P-glycoprotein
  • RNAi

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Targeting glucosylceramide synthase downregulates expression of the multidrug resistance gene MDR1 and sensitizes breast carcinoma cells to anticancer drugs. / Sun, Yanlin; Zhang, Tingguo; Gao, Peng; Meng, Bin; Gao, Yongsheng; Wang, Xiao; Zhang, Jianping; Wang, Hao; Wu, Xiaojuan; Zheng, Wenxin; Zhou, Gengyin.

In: Breast Cancer Research and Treatment, Vol. 121, No. 3, 01.06.2010, p. 591-599.

Research output: Contribution to journalArticle

Sun, Yanlin ; Zhang, Tingguo ; Gao, Peng ; Meng, Bin ; Gao, Yongsheng ; Wang, Xiao ; Zhang, Jianping ; Wang, Hao ; Wu, Xiaojuan ; Zheng, Wenxin ; Zhou, Gengyin. / Targeting glucosylceramide synthase downregulates expression of the multidrug resistance gene MDR1 and sensitizes breast carcinoma cells to anticancer drugs. In: Breast Cancer Research and Treatment. 2010 ; Vol. 121, No. 3. pp. 591-599.
@article{7e42806be739492cbe5a99be71d41897,
title = "Targeting glucosylceramide synthase downregulates expression of the multidrug resistance gene MDR1 and sensitizes breast carcinoma cells to anticancer drugs",
abstract = "Drug resistance in breast cancer remains a major cause for the failure of chemotherapy. Glucosylceramide synthase (GCS) plays an important role in multidrug resistance (MDR) in breast cancer. P-glycoprotein (P-gp) also confers a cross-resistance of many unrelated drugs. In this study, we studied the MDR effect and potential mechanisms of breast cancer after constructing permanent breast cancer cell lines with GCS knockout by using recombinant vectors targeting GCS (pSUPER-GCSshRNAs). The GCSshRNA stably transfected cells were successfully established and significant lower levels of GCS mRNA and protein expression were confirmed. In in vitro experiments, the GCSshRNA stably transfected cells showed a significantly reduced level of MDR1 and P-gp expression and decreased drug efflux ability. Reduced level of GCS expression conveyed a significant reversal of drug resistance by MTT assay and increased caspase-3 activity. In in vivo experiments by using nude mice with xenograft tumors, a significant inhibition of tumor growth was observed after comparing with the control group. Furthermore, enhanced response of chemotherapy was acquired by reduced expression of GCS as well as MDR1 in vivo. In conclusion, GCSshRNA could efficiently suppress GCS and MDR1 expression in vitro and in vivo and these findings may be used as one of the methods to reverse MDR in breast cancer.",
keywords = "Glucosylceramide synthase, MDR1, Multidrug resistance, Nude mice, P-glycoprotein, RNAi",
author = "Yanlin Sun and Tingguo Zhang and Peng Gao and Bin Meng and Yongsheng Gao and Xiao Wang and Jianping Zhang and Hao Wang and Xiaojuan Wu and Wenxin Zheng and Gengyin Zhou",
year = "2010",
month = "6",
day = "1",
doi = "10.1007/s10549-009-0513-z",
language = "English (US)",
volume = "121",
pages = "591--599",
journal = "Breast Cancer Research and Treatment",
issn = "0167-6806",
publisher = "Springer New York",
number = "3",

}

TY - JOUR

T1 - Targeting glucosylceramide synthase downregulates expression of the multidrug resistance gene MDR1 and sensitizes breast carcinoma cells to anticancer drugs

AU - Sun, Yanlin

AU - Zhang, Tingguo

AU - Gao, Peng

AU - Meng, Bin

AU - Gao, Yongsheng

AU - Wang, Xiao

AU - Zhang, Jianping

AU - Wang, Hao

AU - Wu, Xiaojuan

AU - Zheng, Wenxin

AU - Zhou, Gengyin

PY - 2010/6/1

Y1 - 2010/6/1

N2 - Drug resistance in breast cancer remains a major cause for the failure of chemotherapy. Glucosylceramide synthase (GCS) plays an important role in multidrug resistance (MDR) in breast cancer. P-glycoprotein (P-gp) also confers a cross-resistance of many unrelated drugs. In this study, we studied the MDR effect and potential mechanisms of breast cancer after constructing permanent breast cancer cell lines with GCS knockout by using recombinant vectors targeting GCS (pSUPER-GCSshRNAs). The GCSshRNA stably transfected cells were successfully established and significant lower levels of GCS mRNA and protein expression were confirmed. In in vitro experiments, the GCSshRNA stably transfected cells showed a significantly reduced level of MDR1 and P-gp expression and decreased drug efflux ability. Reduced level of GCS expression conveyed a significant reversal of drug resistance by MTT assay and increased caspase-3 activity. In in vivo experiments by using nude mice with xenograft tumors, a significant inhibition of tumor growth was observed after comparing with the control group. Furthermore, enhanced response of chemotherapy was acquired by reduced expression of GCS as well as MDR1 in vivo. In conclusion, GCSshRNA could efficiently suppress GCS and MDR1 expression in vitro and in vivo and these findings may be used as one of the methods to reverse MDR in breast cancer.

AB - Drug resistance in breast cancer remains a major cause for the failure of chemotherapy. Glucosylceramide synthase (GCS) plays an important role in multidrug resistance (MDR) in breast cancer. P-glycoprotein (P-gp) also confers a cross-resistance of many unrelated drugs. In this study, we studied the MDR effect and potential mechanisms of breast cancer after constructing permanent breast cancer cell lines with GCS knockout by using recombinant vectors targeting GCS (pSUPER-GCSshRNAs). The GCSshRNA stably transfected cells were successfully established and significant lower levels of GCS mRNA and protein expression were confirmed. In in vitro experiments, the GCSshRNA stably transfected cells showed a significantly reduced level of MDR1 and P-gp expression and decreased drug efflux ability. Reduced level of GCS expression conveyed a significant reversal of drug resistance by MTT assay and increased caspase-3 activity. In in vivo experiments by using nude mice with xenograft tumors, a significant inhibition of tumor growth was observed after comparing with the control group. Furthermore, enhanced response of chemotherapy was acquired by reduced expression of GCS as well as MDR1 in vivo. In conclusion, GCSshRNA could efficiently suppress GCS and MDR1 expression in vitro and in vivo and these findings may be used as one of the methods to reverse MDR in breast cancer.

KW - Glucosylceramide synthase

KW - MDR1

KW - Multidrug resistance

KW - Nude mice

KW - P-glycoprotein

KW - RNAi

UR - http://www.scopus.com/inward/record.url?scp=77953121237&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77953121237&partnerID=8YFLogxK

U2 - 10.1007/s10549-009-0513-z

DO - 10.1007/s10549-009-0513-z

M3 - Article

C2 - 19693666

AN - SCOPUS:77953121237

VL - 121

SP - 591

EP - 599

JO - Breast Cancer Research and Treatment

JF - Breast Cancer Research and Treatment

SN - 0167-6806

IS - 3

ER -